Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Triptorelin GnRHExplore study findings

What changed when an IVF trial added triptorelin to hCG?

3 numbered sourcesSource years 2025, 2026

Peptides are small strings of amino acids held together by peptide bonds. Some can briefly call an endocrine gland into action. Triptorelin acetate contains a synthetic ten-amino-acid mimic of gonadotropin-releasing hormone, or GnRH. In a 2026 fertility paper, researchers asked whether adding this peptide to human chorionic gonadotropin (hCG) at the final egg-maturation step would improve outcomes for women with diminished ovarian reserve. [1, 2]

Eighty women with a poor ovarian response entered the single-blind randomized study. They were undergoing fertility care that included intracytoplasmic sperm injection, in which a sperm cell is introduced into a retrieved egg. Both groups had the same type of hCG trigger. One group also received triptorelin acetate. The comparison therefore estimates what adding triptorelin did in this particular hCG-containing protocol and selected group. It leaves the effect of triptorelin by itself an open question. [1]

The combination group had more eggs collected, more mature eggs, and more embryos judged good quality under the study's criteria. The investigators also reported a higher implantation rate. The primary outcome was clinical pregnancy, for which they detected no statistically clear difference. Miscarriage rates also had no clear separation. With 80 participants, the trial has limited ability to distinguish modest differences in clinical pregnancy or infrequent outcomes. An increase in the number of mature eggs is a finding about an earlier step and does not establish a change in live births. [1]

A brief pituitary response in this fertility setting and the hormone suppression seen with sustained-release triptorelin involve different exposure patterns. The fertility study used a specific acetate preparation and studied an investigational comparison. The U.S. Trelstar and Triptodur labels apply to their own formulations and indicate advanced prostate cancer and central precocious puberty, respectively. [1, 2, 3]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop Triptorelin GnRH

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.